Version: 2 June 2026
My Medical Gateway (MMG) is a digital marketplace for medical travel, helping UK patients access private surgery abroad. We connect patients with accredited private hospitals across the European Union, providing a structured way to compare, select and book treatment.
NHS waiting lists exceed 7.2 million cases, with the true number likely closer to 9 million. Many patients are seeking faster access to treatment, clearer pricing and a more predictable pathway to care.
Yes. MMG only works with fully licensed and regulated private hospitals within the European Union. All providers go through a structured accreditation process and are experienced in treating international patients.
Medical travel involves going abroad for healthcare, typically to access faster treatment or more competitive pricing than is available domestically.
MMG offers a defined set of elective procedures across 8 specialties, including orthopaedics, general surgery, ENT and ophthalmology. The list focuses on high-demand treatments and continues to expand
Once your diagnosis is confirmed, hospitals will offer you three treatment dates within the following six weeks.
The platform is currently available to permanent UK residents.
Treatment through MMG is typically 20–50% lower than equivalent private surgery in the UK, depending on the procedure and provider.
All treatments are offered as a fixed-price, all-inclusive Treatment Package, which includes:
The package does not include travel to/from the country of treatment, accommodation and sustenance (except for hospital stay) and your diagnostic tests in the UK pre- and post-treatment.
No. Treatment package prices are clearly defined upfront, allowing you to compare providers on a like-for-like basis.
In most cases, medical consultations, diagnostic procedures and surgical treatments provided by accredited hospitals in the UK and the European Union are exempt from VAT. The prices shown on the MMG platform are therefore generally not subject to VAT unless otherwise stated.
All hospitals must meet defined legal, clinical and operational criteria, including full licensing, insurance coverage and the ability to deliver MMG’s Treatment Package. Each provider is assessed through a structured accreditation process.
Yes. Many EU private hospitals operate at a comparable standard, often with modern facilities and experienced clinical teams. Pricing differences are primarily driven by system costs, not lower standards of care.
You select a treatment, compare providers and receive a fixed-price quote. Once you choose a hospital, the MMG platform automatically coordinates onboarding, diagnostics, booking and payment through a structured process.
After your diagnosis is confirmed based on the tests supplied by you, your hospital will offer available dates, typically within six weeks.
Remote diagnosis allows your chosen hospital to review your medical test results before you travel, so your treatment plan can be confirmed in advance.
In most cases, yes. Hospitals require recent diagnostic tests, usually no more than 30 days old, from a recognised provider.
No. Your diagnostic data is shared directly with your hospital. MMG does not store or review clinical information.
Your Treatment Package includes post-operative care and follow-up, including remote clinical review and support from your hospital.
Your hospital is responsible for treatment-related aftercare under your Healthcare Contract. You can contact them directly for support, including remote consultation.
For urgent issues, you should use NHS services (111, A&E) as normal.
Yes. You remain entitled to NHS care. Access is based on clinical need and local availability, as with any patient.
All payments are processed securely through Adyen, a regulated EU payments provider.
Yes. You can cancel for a full refund within 14 days of your initial payment.
If your hospital determines you are not suitable for treatment, you will receive a full refund of your initial payment.
Yes, it is strongly recommended. Insurance can cover travel disruption, cancellations and additional care if required.
Since 10 April 2026, the European Union’s new Entry/Exit System (EES) has been fully operational across the 29 Schengen countries. The system replaces manual passport stamping for non-EU visitors with digital registration. On first entry into the Schengen area, visitors will typically undergo fingerprint and facial recognition registration to monitor permitted 90-day stays. The new ETIAS pre-travel electronic authorisation system is currently scheduled to become operational in the last quarter of 2026.
Yes. You can share your referral link and receive a reward when someone you refer completes treatment through MMG.